Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer - PubMed (original) (raw)
Review
doi: 10.1038/nrc1926.
Affiliations
- PMID: 16794634
- DOI: 10.1038/nrc1926
Review
Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer
Brian Bierie et al. Nat Rev Cancer. 2006 Jul.
Abstract
Transforming growth factor-beta (TGFbeta) signalling regulates cancer through mechanisms that function either within the tumour cell itself or through host-tumour cell interactions. Studies of tumour-cell-autonomous TGFbeta effects show clearly that TGFbeta signalling has a mechanistic role in tumour suppression and tumour promotion. In addition, factors in the tumour microenvironment, such as fibroblasts, immune cells and the extracellular matrix, influence the ability of TGFbeta to promote or suppress carcinoma progression and metastasis. The complex nature of TGFbeta signalling and crosstalk in the tumour microenvironment presents a unique challenge, and an opportunity to develop therapeutic intervention strategies for targeting cancer.
Similar articles
- Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
Gal A, Sjöblom T, Fedorova L, Imreh S, Beug H, Moustakas A. Gal A, et al. Oncogene. 2008 Feb 21;27(9):1218-30. doi: 10.1038/sj.onc.1210741. Epub 2007 Aug 27. Oncogene. 2008. PMID: 17724470 - Targeting TGFbeta-mediated processes in cancer.
Romano MF. Romano MF. Curr Opin Drug Discov Devel. 2009 Mar;12(2):253-63. Curr Opin Drug Discov Devel. 2009. PMID: 19333871 Review. - Roles of TGFbeta in metastasis.
Padua D, Massagué J. Padua D, et al. Cell Res. 2009 Jan;19(1):89-102. doi: 10.1038/cr.2008.316. Cell Res. 2009. PMID: 19050696 Review. - A delicate balance: TGF-beta and the tumor microenvironment.
Stover DG, Bierie B, Moses HL. Stover DG, et al. J Cell Biochem. 2007 Jul 1;101(4):851-61. doi: 10.1002/jcb.21149. J Cell Biochem. 2007. PMID: 17486574 Review. - Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
Di Sabatino A, Jackson CL, Pickard KM, Buckley M, Rovedatti L, Leakey NA, Picariello L, Cazzola P, Monteleone G, Tonelli F, Corazza GR, MacDonald TT, Pender SL. Di Sabatino A, et al. Gut. 2009 Jun;58(6):777-89. doi: 10.1136/gut.2008.149096. Epub 2009 Feb 6. Gut. 2009. PMID: 19201776
Cited by
- The perivascular niche regulates breast tumour dormancy.
Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, Chen EI, Lyden D, Bissell MJ. Ghajar CM, et al. Nat Cell Biol. 2013 Jul;15(7):807-17. doi: 10.1038/ncb2767. Epub 2013 Jun 2. Nat Cell Biol. 2013. PMID: 23728425 Free PMC article. - SnoN in regulation of embryonic development and tissue morphogenesis.
Zhu Q, Luo K. Zhu Q, et al. FEBS Lett. 2012 Jul 4;586(14):1971-6. doi: 10.1016/j.febslet.2012.03.005. Epub 2012 Mar 10. FEBS Lett. 2012. PMID: 22710172 Free PMC article. Review. - Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.
Engels EA, Jennings L, Kemp TJ, Chaturvedi AK, Pinto LA, Pfeiffer RM, Trotter JF, Acker M, Onaca N, Klintmalm GB. Engels EA, et al. Cancer Med. 2015 Aug;4(8):1252-7. doi: 10.1002/cam4.455. Epub 2015 Apr 27. Cancer Med. 2015. PMID: 25919050 Free PMC article. - Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.
Jahchan NS, Ouyang G, Luo K. Jahchan NS, et al. PLoS One. 2013;8(2):e55794. doi: 10.1371/journal.pone.0055794. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418461 Free PMC article. - RET is a potential tumor suppressor gene in colorectal cancer.
Luo Y, Tsuchiya KD, Il Park D, Fausel R, Kanngurn S, Welcsh P, Dzieciatkowski S, Wang J, Grady WM. Luo Y, et al. Oncogene. 2013 Apr 18;32(16):2037-47. doi: 10.1038/onc.2012.225. Epub 2012 Jul 2. Oncogene. 2013. PMID: 22751117 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources